Canada markets open in 7 hours 6 minutes

Bicycle Therapeutics plc (BCYC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
24.20+0.75 (+3.20%)
At close: 04:00PM EDT
24.20 0.00 (0.00%)
After hours: 05:33PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 918.81M
Enterprise Value 437.34M
Trailing P/E 1.84k
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)31.93
Price/Book (mrq)2.48
Enterprise Value/Revenue 16.21
Enterprise Value/EBITDA -2.58

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 315.79%
S&P500 52-Week Change 323.57%
52 Week High 328.91
52 Week Low 312.54
50-Day Moving Average 323.98
200-Day Moving Average 320.29

Share Statistics

Avg Vol (3 month) 3396.39k
Avg Vol (10 day) 3337.71k
Shares Outstanding 537.97M
Implied Shares Outstanding 636.71M
Float 8N/A
% Held by Insiders 11.64%
% Held by Institutions 1105.41%
Shares Short (Apr 15, 2024) 42.96M
Short Ratio (Apr 15, 2024) 47.04
Short % of Float (Apr 15, 2024) 48.58%
Short % of Shares Outstanding (Apr 15, 2024) 47.80%
Shares Short (prior month Mar 15, 2024) 42.56M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,017.35%

Management Effectiveness

Return on Assets (ttm)-23.60%
Return on Equity (ttm)-56.31%

Income Statement

Revenue (ttm)26.98M
Revenue Per Share (ttm)0.76
Quarterly Revenue Growth (yoy)67.40%
Gross Profit (ttm)N/A
EBITDA -183.4M
Net Income Avi to Common (ttm)-180.66M
Diluted EPS (ttm)-5.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)526.42M
Total Cash Per Share (mrq)12.36
Total Debt (mrq)44.96M
Total Debt/Equity (mrq)12.12%
Current Ratio (mrq)8.08
Book Value Per Share (mrq)8.74

Cash Flow Statement

Operating Cash Flow (ttm)-60.63M
Levered Free Cash Flow (ttm)-75.43M